Hedge Fund - Eversept Partners
Glaxosmithkline Plc (GSK)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2022 - Q3 (2022-09-30) | $0 | 0% | 0 | $36.31 |
| 2 | 2022 - Q2 (2022-06-30) | $69,912,586 | 4.97% | 1,563,513.8,768 | $44.16 |
| 3 | 2022 - Q1 (2022-03-31) | $55,533,447 | 4.26% | 1,234,986.0,896 | $43.45 |
| 4 | 2021 - Q4 (2021-12-31) | $25,039,082 | 1.59% | 556,314.664 | $41.61 |
| 5 | 2021 - Q3 (2021-09-30) | $15,410,002 | 1.06% | 393,942.2,432 | $40.18 |
| 6 | 2021 - Q2 (2021-06-30) | $4,613,279 | 0.3% | 110,515.5,632 | $38.44 |
| 7 | 2021 - Q1 (2021-03-31) | $31,057,290 | 2.33% | 835,843.6,448 | $36.31 |
| 8 | 2020 - Q4 (2020-12-31) | $35,196,522 | 4.12% | 928,406.6,448 | $36.75 |
| 9 | 2020 - Q3 (2020-09-30) | $2,453,292 | 0.54% | 63,136.0,576 | $40.08 |
| 10 | 2020 - Q2 (2020-06-30) | $9,270,058 | 1.27% | 222,899.5,504 | $41.04 |
| 11 | 2020 - Q1 (2020-03-31) | $19,855,305 | 4.93% | 500,768.0,368 | $42.67 |
| 12 | 2019 - Q4 (2019-12-31) | $48,578,465 | 8.57% | 1,003,441.768 | $44.50 |
| 13 | 2019 - Q3 (2019-09-30) | $42,337,144 | 13.13% | 964,209.768 | $41.15 |
| 14 | 2019 - Q2 (2019-06-30) | $28,091,890 | 7.86% | 680,366.248 | $40.14 |
| 15 | 2019 - Q1 (2019-03-31) | $34,065,052 | 9.93% | 787,763.848 | $39.98 |
| 16 | 2018 - Q4 (2018-12-31) | $20,391,894 | 11.04% | 519,317.9,072 | $39.40 |
| 17 | 2018 - Q3 (2018-09-30) | $11,745,720 | 5.15% | 283,729.7,472 | $40.64 |
| 18 | 2018 - Q2 (2018-06-30) | $10,315,317 | 4.71% | 247,734.3,872 | $40.29 |
| 19 | 2018 - Q1 (2018-03-31) | $8,948,163 | 4.15% | 222,233.5,872 | $37.26 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
613.0000:500.0000 on 2022-07-22
-
4.0000:5.0000 on 2022-07-19
Hedge Fund Resource Center